Halep examined constructive for roxadustat, an anti-anaemia drug which stimulates the manufacturing of crimson blood cells within the physique.
In Might 2023, Halep was handed a second cost by the Worldwide Tennis Integrity Company (ITIA), this time for irregularities in her athlete organic passport (ABP).
An impartial report, instigated by the ITIA, dominated Halep had “deliberately” doped and handed out a four-year ban.
Halep appealed in opposition to the choice and on Tuesday it was introduced her case was partially upheld, with Cas ruling Halep “on the stability of possibilities” had not taken roxadustat deliberately.
The cost regarding the discrepancies in her athlete organic passport was dismissed by Cas.
Halep’s suspension was minimize to 9 months and backdated to the beginning of her provisional suspension in October 2022, that means she is ready to return to competitors within the coming weeks.
Halep mentioned the ruling was a “pivotal second” which offered “readability”.
If the unique suspension till October 2026 had stood, she would have simply turned 35 when allowed to return.
“Within the midst of this difficult journey, my unwavering perception within the integrity of the reality and within the rules of justice has been my beacon,” she mentioned.
“Trying ahead, I’m keen to show this web page and rejoin the tour with renewed vigour and an invigorated spirit.”
